New study investigates why BIPOC patients may not get the antidepressants they need
NCT ID NCT06799078
First seen May 09, 2026 · Last updated May 09, 2026
Summary
This study looks at whether Black, Indigenous, and People of Color (BIPOC) face more barriers to starting or sticking with antidepressants after a one-time psychiatric consultation for depression. Researchers will survey 60 adults diagnosed with depression three months after their consultation to see if race affects medication recommendations, starting or switching drugs, dosage, and adherence. The goal is to understand these differences and help create fairer treatment strategies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION DISORDERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre for Addiction and Mental Health
Toronto, Ontario, M5S 2S1, Canada
Conditions
Explore the condition pages connected to this study.